The purpose of the study: obtaining knowledge about the impact of Snoezelen® therapy on the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol.
The main questions it aims to answer are:
Does Snoezelen therapy improve the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol?
The participant will participate in Snoezelen® therapy for 6 or 12 weeks, 2 times a week (30 minutes each session).
Adults suffering from schizophrenia requiring permanent institutional care, N=40
women and men aged ≥ 18 years,
consent of the patient or legal guardian to participate in the study,
schizophrenia clinically confirmed for at least 5 years, with predominance of negative symptoms,
lack of consent to participate in the study;
pregnancy;
general contraindications (acute inflammatory and febrile diseases, venous thrombosis, unstable arterial hypertension, early condition after contrast computed tomography, early condition after lumbar puncture, general serious condition of the patient);
unstable or untreated epilepsy, based on EEG;
The Jerzy Kukuczka Academy of Physical Education in Katowice
Lead sponsor
Clinical Psychiatric Hospital SPZOZ in Rybnik, Poland
Collaborator